Breaks Categories: News

MondayFeb 26, 2018 9:29 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Licensing Agreement with Neutrisci International Inc. (TSX-V: NU) (OTCQB: NRXCF)

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning said it has entered an agreement with NeutriSci International Inc. (TSX-V: NU) (OTCQB: NRXCF) resulting in NeutriSci now having 100% ownership of Ambarii Trade Corporation. Lexaria has also granted to NeutriSci an Intellectual Property License and Supply Agreement for the manufacturing and sale of CBD based products. Per the License Agreement, NeutriSci will remain focused on the development and sales of its existing and pipeline products that include Lexaria's technology for enhancing palatability and bioavailability of beneficial non-psychoactive cannabinoids. Lexaria will receive continuing royalty revenues from the sales generated by these products.…

Continue Reading

TuesdayFeb 20, 2018 9:56 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Expands hempSMART™ Line with Full Spectrum Pet Drops

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced the release of hempSMART™ Full Spectrum Pet Drops, a natural product line formulated with 250mg of full spectrum non-psychoactive cannabidiol (“CBD”) derived from industrial hemp. Per the update, in addition to naturally-occurring CBD, the specially-formulated product contains full spectrum hemp extract, fractionated coconut oil and a rich bacon flavor. “Our new hempSMART product is a natural option for pet owners who care about supporting their animals’ healthy energy levels as well as optimizing their health,” Donald Steinberg, CEO of MCOA, stated in the news release. “Our…

Continue Reading

ThursdayJan 11, 2018 11:31 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Subsidiary Announces Launch of hempSMART™ Pain Cream

Marijuana Company of America, Inc. (OTC: MCOA), through wholly owned subsidiary hempSMART™, Inc., this morning announced the launch of hempSMART Pain Cream. Per the update, each bottle of hempSMART Pain Cream is formulated with 300mg of full spectrum non-psychoactive cannabidiol derived from industrial hemp. Utilizing a proprietary blend of Ayurvedic herbs, menthol, cayenne pepper extract, rosemary oil, aloe gel, white willow bark, arnica, wintergreen extract and tea tree oil, hempSMART Pain Cream provides what the company calls an immediate cooling and soothing sensation. “We are excited to announce the expansion of our hempSMART personal care product line to include pain…

Continue Reading

ThursdayDec 14, 2017 10:36 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Adds New Pain Product to Lineup

Marijuana Company of America (OTC: MCOA) announced today the launch of its new personal care product hempSMART Pain for the temporary treatment of minor pain associated with physical activity using non-psychoactive cannabidiol. "HempSMART demonstrated its commitment to formulating a safe and synergistic natural personal care product. The hempSMART Pain formula harnesses the natural power of premium CBD, CBG and active terpenes derived from industrial hemp, combined with complimentary botanicals,” Paula Vetter, a member of hempSMART's product development team, stated in a news release about the product. To view the full press release, visit http://cnw.fm/G61Yr. About Marijuana Company of America, Inc.…

Continue Reading

WednesdayOct 18, 2017 11:29 am

PsychedelicNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters Collaboration Agreement with Phasex Corporation

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced supercritical fluid (“SCF”)-based toll processors. The goal of the collaboration is to combine PBI’s recently patented Ultra Shear Technology with Phasex’s SCF-based processing methods to enable the development of stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil. “Rapidly expanding markets for non-psychoactive extracts of cannabis plant material, for instance, is an example of a potentially high demand application for our combined, synergistic technologies,” Richard…

Continue Reading

FridayOct 13, 2017 11:34 am

PsychedelicNewsBreaks – International Endeavors Corp. (IDVV) Enters MOU with Kubby Cryogenics, Inc. to Expand Medical Cannabis Line

International Endeavors (OTC: IDVV) this morning said that it has signed a memorandum of understanding (MOU) with Kubby Cryogenics, Inc. Per the agreement, Kubby Cryogenics will seek to patent medical grade cannabis strains that are genetically profiled to treat specific diseases. The agreement also states that Steve Kubby will immediately become CEO of International Endeavors. Kubby Cryogenics has assembled a team of top scientists and geneticists to continue developing the company’s proprietary cryogenics products. "We will create a dispensary system for legal medical cannabis states standardizing the patient centered, consultation approach while presenting an enticing line of Adult Use products…

Continue Reading

TuesdayOct 03, 2017 9:28 am

PsychedelicNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Announces Filing of Provisional Patent for Cannabinoid-Based Pain Treatment

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the filing of a provisional patent application in the United States for INM-405 and other unique compositions as cannabinoid-based topical therapies for the treatment of pain, marking an important step toward protection of the company’s intellectual and commercial property. “There remains a significant need in the field of analgesia for a product that can treat pain via a topical route of administration, which would reduce systemic exposure and any associated side effects,” Dr. Sazzad Hossain, chief scientific officer of InMed and a co-inventor on the newly-filed…

Continue Reading

ThursdayAug 10, 2017 9:32 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Discusses Company’s Progress in Interview

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced that its chief executive officer, Chris Bunka, was featured in a recent interview on the Uptick Network Stock Day Radio Show. Bunka leveraged the platform to discuss Lexaria’s overall accomplishments in the past three months, as well as the company’s expectations for profitability moving forward. He notes that ongoing research and development programs could open both the NSAID and Nicotine markets to Lexaria, providing an opportunity to significantly increase corporate revenues and facilitate further expansion. “In the…

Continue Reading

WednesdayAug 02, 2017 3:23 pm

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Spotlighted by Technical420

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, including cannabinoids, was recently spotlighted in an article on Technical420.com. The publication highlighted, in detail, several of the company’s key developments and growth catalysts. “During the last few months, Lexaria has improved its fundamental story through the following developments: 1) The company applied for a new patent from the U.S., 2) Lexaria has advanced its agreements and launched new businesses, 3) Expands its Reach into Asia, 4) Focused on R&D with major organizations, and 5) The company’s cash position has…

Continue Reading

TuesdayJul 18, 2017 12:19 pm

PsychedelicNewsBreaks – Algae Dynamics Corp. (ADYNF) Featured in Exclusive Audio Interview by PsychedelicNewsWire

Multifaceted financial news and publishing company PsychedelicNewsWire (“PNW”) this morning announced the online availability of an exclusive audio interview with Algae Dynamics Corp. (OTCQB: ADYNF). In the interview, Paul Ramsay, president and chairman of Algae Dynamics, provides insight into the company’s operational focus on the development of unique health products and pharmaceuticals utilizing cannabis, hemp and algae oils. “We're working with cannabis in isolation, but we are also formulating different combinations of algae mixed with cannabis oils. It's quite an interesting program and quite exciting given the health benefits,” Ramsay noted. “We're doing this because we have a lot of…

Continue Reading